Basis: Current FMP quote-based enterprise value / four-quarter operating income. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBIT ratio is N/A as of 2026-10-06T16:04:09.306Z.
Calculation as of: 2026-10-06T16:04:09.306Z.
Quote observation: 2026-10-06T15:59:48.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: c001abb9fb130ee2b6508d8c6936c8922234201b227c8e733dd2d15e066cad3f
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBIT RATIO
N/A
MetaVia Inc.
Market Cap
$9.68M
EV/EBIT Ratio
N/A
| NAME | MARKET CAP | EV/EBIT RATIO |
|---|---|---|
| MetaVia Inc. (MTVA) | $9.68M | N/A |
| Ainos, Inc. (AIMD)vs › | $9.79M | N/A |
| NeuroOne Medical Technologies Corporation (NMTC)vs › | $10.01M | N/A |
| Jasper Therapeutics, Inc. (JSPR)vs › | $9.34M | N/A |
| Medicus Pharma Ltd. Common Stock (MDCX)vs › | $10.06M | N/A |
| Advanced Biomed Inc. Common Stock (ADVB)vs › | $9.22M | N/A |
| SeaStar Medical Holding Corporation (ICU)vs › | $9.29M | N/A |
| Satellos Bioscience Inc. (MSLE)vs › | $10.44M | N/A |
| CytoMed Therapeutics Limited (GDTC)vs › | $10.77M | N/A |
| Polyrizon Ltd. (PLRZ)vs › | $10.53M | N/A |
EV/EBIT = Enterprise Value / EBIT (TTM)
Enterprise value to EBIT compares total company value to operating earnings, accounting for depreciation unlike EV/EBITDA.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
